Loading...
Decrease in JAK2(V617F) allele burden is not a prerequisite to clinical response in patients with polycythemia vera
BACKGROUND: Although reduction in the JAK2(V617F) allele burden (%V617F) has been suggested as a criterion for defining disease response to cytoreductive therapy in polycythemia vera, its value as a response monitor is unclear. The purpose of this study is to determine whether a reduction in %V617F...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ferrata Storti Foundation
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3347655/ https://ncbi.nlm.nih.gov/pubmed/22102708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.053348 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|